Similarly, investigations indicated that transferring fecal samples from type 2 diabetes patients treated with DPP-4 inhibitors into germ-free mice improved glucose tolerance, particularly in response to impairments induced by high-density lipoprotein cholesterol (118). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.